Analysis of HNE metabolism in CNS models

Redox Report

Volumn 12, Issue 1-2, 2007, Pages 16-19

  Kubatova, Alena ^a   Honzatko, Ales ^a   Brichac, Jiri ^a   Long, Eric ^a   Picklo, Matthew J ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Central nervous system; Stereocenter; Trans 4 hydroxy 2 nonenal

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE;

ANALYTIC METHOD; ASTROCYTE; BRAIN MITOCHONDRION; CELL FUNCTION; CELL INTERACTION; CELL METABOLISM; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; CHEMICAL STRUCTURE; CHIRALITY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONJUGATION; DETOXIFICATION; ENANTIOMER; HUMAN; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MITOCHONDRIAL RESPIRATION; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEREOCHEMISTRY;

ALDEHYDES; ALZHEIMER DISEASE; ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; MITOCHONDRIA, HEART; MODELS, NEUROLOGICAL; OXIDATION-REDUCTION; PARKINSON DISEASE;

EID: 33846827400     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100007X162149     Document Type: Conference Paper

References (22)

1. Picklo MJ, Montine TJ, Amarnath V, Neely MD. Carbonyl toxicology and Alzheimer's disease. Toxicol Appl Pharmacol 2002; 184: 187-197.
2. Zarkovic K. 4-Hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 2003; 24: 293-303.
3. Petersen DR, Doorn JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004, 37: 937-945.
4. Mattson MP, Fu W, Waeg G, Uchida K. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. Neuroreport 1997; 8: 2275-2281.
5. Keller JN, Pang Z, Geddes JW et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 1997; 69: 273-284.
6. Srivastava S, Conklin DJ, Liu S et al. Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells. Atherosclerosis 2001; 158: 339-350.
7. Mitchell DY, Petersen DR. Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase-mediated acetylaldehyde oxidation by trans-4-hydroxy-2-nonenal. Hepatology 1991; 13: 728-734.
8. T jalkens RB, Cook LW, Petersen DR. Formation and export of the glutathione conjugate of 4-hydroxy-2, 3-E-nonenal (4-HNE) in hepatoma cells. Arch Biochem Biophys 1999; 361: 113-119.
9. Kunstmann S, Mertsch K, Blasig IE, Grune T. High metabolic rates of 4-hydroxynonenal in brain capillary endothelial cells during hypoxia/ reoxygenation. Brain Res 1996; 740: 353-355.
10. Picklo MJ, Amarnath V, McIntyre JO, Graham DG, Montine TJ. 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. J Neurochem 1999; 72: 1617-1624.
11. + availability. Chem Res Toxicol 2004; 17: 1272-1279.
12. Ullrich O, Grune T, Henke W, Esterbauer H, Siems WG. Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal by mitochondria isolated from rat kidney cortex. FEBS Lett 1994; 352: 84-86.
13. Murphy TC, Amarnath V, Gibson KM, Picklo Sr MJ. Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A). J Neurochem 2003; 86: 298-305.
14. Hiratsuka A, Saito H, Hirose K, Watabe T. Marked expression of glutathione S-transferase A4-4 detoxifying 4-hydroxy-2(E)-nonenal in the skin of rats irradiated by ultraviolet B-band light (UVB). Biochem Biophys Res Commun 1999; 260: 740-746.
15. Hiratsuka A, Tobita K, Saito H et al. (S)-preferential detoxification of 4-hydroxy-2(E)-nonenal enantiomers by hepatic glutathione S-transferase, isoforms in guinea-pigs and rats. Biochem J 2001; 355: 237-244.
16. Hashimoto M, Sibata T, Wasada H, Toyokuni S, Uchida K. Structural basis of protein-bound endogenous aldehydes. Chemical and immunochemical characterizations of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct. J Biol Chem 2003; 278: 5044-5051.
17. Honzatko A, Brichac J, Murphy TC et al. Enantioselective metabolism of trans-4-hydroxy-2-nonenal by brain mitochondria. Free Radic Biol Med 2005; 39: 913-924.
18. Leiphon LJ, Picklo Sr MJ. Inhibition of aldehyde detoxification in CNS mitochondria by fungicides. Neurotoxicology 2007; In press.
19. Kubatova A, Murphy TC, Combs C, Picklo Sr MJ. Astrocytic biotransformation of trans-4-hydroxy-2-nonenal is dose-dependent. Chem Res Toxicol 2006; 19: 844-851.
20. 4 12-hydroxydehydrogenase/ 15-oxoprostaglandin 13-reductase. J Biol Chem 2001; 276: 40803-40810.
21. Picklo MJ, Olson SJ, Markesbery WR, Montine TJ. Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60: 686-695.
22. Sidell KR, Montine KS, Picklo Sr MJ, Olsen SJ, Amarnath V, Montine TJ. Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum. J Neuropathol Exp Neurol 2003; 62: 146-153.